CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Head & Neck Cancers
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Oncology Nursing News
Precision Medicine in Oncology
Special Reports in Personalized Cancer Care
SELECT A TOPIC
Stay tuned for our LIVE OncLive News Network coverage straight from the #ASH18 conference floor!
<< View More Conferences
ATA Annual Meeting
Oncology Conference Multimedia
View more videos >>
Dr. Brose Discusses Lenvatinib and Sorafenib in Differentiated Thyroid Cancer
Dr. Sosa Discusses Molecular Testing in Thyroid Cancer
Dr. Ganly on a Postoperative Nomogram for Predicting Cancer-Specific Mortality in MTC
Oncology Conference Articles
Novel NGS Test May Enhance Diagnosis and Management of Indeterminate Thyroid Nodules
A next-generation sequencing assay has shown promise as a new tool to aid in the diagnosis and treatment of indeterminate thyroid nodules.
Next-Generation Sequencing Effectively Detects Cancer in Thyroid Nodules
The ThyroSeq v2 next-generation sequencing assay was highly accurate at diagnosing cancer in thyroid nodules with follicular neoplasm or those suspected of follicular neoplasm cytology.
Vitamin D Levels Predict Hypocalcemia After Thyroid Cancer Treatment
Preoperative vitamin D deficiency is associated with postoperative symptomatic hypocalcemia in patients with thyroid cancer undergoing total thyroidectomy plus central compartment neck dissection.
Novel Therapeutic Target Identified in Aggressive Thyroid Cancers
In vivo models for two aggressive thyroid cancers have shown that downregulation of miR-30a-5p leads to overexpression of LOX, a target which appears amenable to treatment with Î²-aminopropionitrile fumarate.
New Assay Effectively Detects Circulating BRAFV600E in Patients With Papillary Thyroid Cancer
The detection of BRAFV600E in patients with papillary thyroid cancer using a blood-based assay was shown to be feasible in a cohort of patients undergoing thyroidectomy.
ATA Highlights New Thyroid Cancer Research
The impact of RAI on long-term outcomes, potential combination strategies, molecular profiling, and novel therapeutics for patients with thyroid cancer were among some of the topics highlighted at the 2014 ATA Annual Meeting.
Moderate THST Improves Outcomes in Differentiated Thyroid Cancer
Long-term moderate thyroid hormone suppression therapy is associated with improved outcomes in patients with differentiated thyroid cancer.
Disease-Related Variables Predictive of Outcomes With Sorafenib in DTC
Numerous disease-related variables could serve as prognostic and predictive factors for treatment outcomes with sorafenib in patients with radioactive iodine-refractory differentiated thyroid cancer.
PD-1 Immunotherapies Induce Painless Thyroiditis in Patients With Metastatic Malignancies
Treatment with PD-1 immunotherapy across various oncology clinical trials has been associated with the induction of painless thyroiditis, characterized by transient thyrotoxicosis and hypothyroidism, in patients with metastatic malignancies
Molecular Diagnostics Focus on Thyroid Nodule Classification
New data being presented at the 84th Annual Meeting of the American Thyroid Association show promise for two molecular tests that help identify indeterminate thyroid nodules as either benign or malignant.
Future Research and the Clinical Management of mCRC
Dabrafenib Plus Trametinib Demonstrates Activity in GI Cancers
FDA Approves Frontline Eltrombopag for Severe Aplastic Anemia
Novel Drug Combination Shows Early Activity in Microsatellite Stable CRC
Durvalumab Combo Misses OS Endpoint in Frontline Metastatic NSCLC
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
2 Clarke Drive
Cranbury, NJ 08512
Copyright OncLive 2006-2018
Intellisphere, LLC. All Rights Reserved.